Related Experiment Videos
Interleukin-6 and its relation to inflammation and disease
1Division of Molecular Oncology, Osaka University Medical School, Japan.
Clinical Immunology and Immunopathology
|January 1, 1992
Summary
Interleukin-6 (IL-6) drives autoimmune diseases and plasma cell cancers. IL-6 transgenic mice developed plasmacytosis and glomerulonephritis, confirming its critical role in these conditions.
Area of Science:
- Immunology
- Molecular Biology
- Pathology
Background:
- Interleukin-6 (IL-6) is a key cytokine regulating immune responses, acute phase reactions, and hematopoiesis.
- The IL-6 receptor system involves a ligand-binding molecule and the signal transducer gp 130, both part of the cytokine receptor family.
- Aberrant IL-6 gene expression is linked to the pathogenesis of autoimmune diseases and plasma cell neoplasias.
Purpose of the Study:
- To investigate the role of Interleukin-6 (IL-6) in the development of plasma cell abnormalities and glomerulonephritis.
- To understand the implications of deregulated IL-6 gene expression in disease pathogenesis.
Main Methods:
- Utilized IL-6 transgenic C57BL/6 mice model.
- Observed and analyzed the development of plasmacytosis, autoantibody production, and mesangial proliferative glomerulonephritis.
Main Results:
- IL-6 transgenic mice exhibited massive polyclonal plasmacytosis.
- These mice produced autoantibodies.
- Mesangial proliferative glomerulonephritis was observed in the transgenic mice.
Conclusions:
- Interleukin-6 (IL-6) plays a critical role in the development of plasma cell abnormalities.
- IL-6 is implicated in the pathogenesis of glomerulonephritis.
- The study highlights IL-6's significance in autoimmune diseases and plasma cell neoplasias.